1. Home
  2. HUMA vs DPRO Comparison

HUMA vs DPRO Comparison

Compare HUMA & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.35

Market Cap

308.6M

Sector

Health Care

ML Signal

HOLD

Logo Draganfly Inc.

DPRO

Draganfly Inc.

HOLD

Current Price

$6.26

Market Cap

272.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUMA
DPRO
Founded
2004
1998
Country
United States
Canada
Employees
184
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
308.6M
272.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
HUMA
DPRO
Price
$1.35
$6.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
3
Target Price
$6.19
$15.00
AVG Volume (30 Days)
7.8M
2.2M
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$444.16
$158.69
Revenue Next Year
$248.39
$131.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$2.08
52 Week High
$2.84
$14.37

Technical Indicators

Market Signals
Indicator
HUMA
DPRO
Relative Strength Index (RSI) 62.33 49.48
Support Level $0.89 $6.23
Resistance Level $1.72 $6.74
Average True Range (ATR) 0.13 0.58
MACD 0.03 0.05
Stochastic Oscillator 75.52 38.20

Price Performance

Historical Comparison
HUMA
DPRO

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The two segments are Drones, and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

Share on Social Networks: